BACKGROUND: With this study, we sought to identify patient characteristics associated with clopidogrel prescription and its relationship with in-hospital adverse events in an unselected cohort of ACSs patients. MATERIALS AND METHODS: We studied all consecutive patients admitted at our institution for ACSs from 2012 to 2014. Patients were divided into two groups based on clopidogrel or novel P2Y12 inhibitors (prasugrel or ticagrelor) prescription and the relationship between clopidogrel use and patient clinical characteristics and in-hospital adverse events was evaluated using logistic regression analysis. RESULTS: The population median age was 68 years (57-77 year) and clopidogrel was prescribed in 230 patients (46%). Patients characteristics associated with clopidogrel prescription were older age, female sex, non-ST-elevation ACS diagnosis, the presence of diabetes mellitus and anemia, worse renal and left ventricular functions and a higher Killip class. Patients on clopidogrel demonstrated a significantly higher incidence of in-hospital mortality (4.8%) than prasugrel and ticagrelor-treated patients (0.4%), while a nonstatistically significant trend emerged considering bleeding events. However, on multivariable logistic regression analysis female sex, the presence of anemia and Killip class were the only variables independently associated with in-hospital death. CONCLUSION: Patients treated with clopidogrel showed a higher in-hospital mortality. However, clinical variables associated with its use identify a population at high risk for adverse events and this seems to play a major role for the higher in-hospital mortality observed in clopidogrel-treated patients.
BACKGROUND: With this study, we sought to identify patient characteristics associated with clopidogrel prescription and its relationship with in-hospital adverse events in an unselected cohort of ACSs patients. MATERIALS AND METHODS: We studied all consecutive patients admitted at our institution for ACSs from 2012 to 2014. Patients were divided into two groups based on clopidogrel or novel P2Y12 inhibitors (prasugrel or ticagrelor) prescription and the relationship between clopidogrel use and patient clinical characteristics and in-hospital adverse events was evaluated using logistic regression analysis. RESULTS: The population median age was 68 years (57-77 year) and clopidogrel was prescribed in 230 patients (46%). Patients characteristics associated with clopidogrel prescription were older age, female sex, non-ST-elevation ACS diagnosis, the presence of diabetes mellitus and anemia, worse renal and left ventricular functions and a higher Killip class. Patients on clopidogrel demonstrated a significantly higher incidence of in-hospital mortality (4.8%) than prasugrel and ticagrelor-treated patients (0.4%), while a nonstatistically significant trend emerged considering bleeding events. However, on multivariable logistic regression analysis female sex, the presence of anemia and Killip class were the only variables independently associated with in-hospital death. CONCLUSION:Patients treated with clopidogrel showed a higher in-hospital mortality. However, clinical variables associated with its use identify a population at high risk for adverse events and this seems to play a major role for the higher in-hospital mortality observed in clopidogrel-treated patients.
Authors: Carlo Patrono; Fedor Bachmann; Colin Baigent; Christopher Bode; Raffaele De Caterina; Bernard Charbonnier; Desmond Fitzgerald; Jack Hirsh; Steen Husted; Jan Kvasnicka; Gilles Montalescot; Luis Alberto García Rodríguez; Freek Verheugt; Jozef Vermylen; Lars Wallentin; Silvia G Priori; Maria Angeles Alonso Garcia; Jean Jacques Blanc; Andrzej Budaj; Martin Cowie; Veronica Dean; Jaap Deckers; Enrique Fernández Burgos; John Lekakis; Bertil Lindahl; Gianfranco Mazzotta; João Morais; Ali Oto; Otto A Smiseth; João Morais; Jaap Deckers; Rafael Ferreira; Gianfranco Mazzotta; Philippe Gabriel Steg; Frederico Teixeira; Robert Wilcox Journal: Eur Heart J Date: 2004-01 Impact factor: 29.983
Authors: M B Yudi; D J Clark; O Farouque; D Eccleston; N Andrianopoulos; S J Duffy; A Brennan; J Lefkovits; J Ramchand; T Yip; E Oqueli; C M Reid; A E Ajani Journal: Intern Med J Date: 2016-05 Impact factor: 2.048
Authors: Roxana Mehran; Sunil V Rao; Deepak L Bhatt; C Michael Gibson; Adriano Caixeta; John Eikelboom; Sanjay Kaul; Stephen D Wiviott; Venu Menon; Eugenia Nikolsky; Victor Serebruany; Marco Valgimigli; Pascal Vranckx; David Taggart; Joseph F Sabik; Donald E Cutlip; Mitchell W Krucoff; E Magnus Ohman; Philippe Gabriel Steg; Harvey White Journal: Circulation Date: 2011-06-14 Impact factor: 29.690
Authors: Dean J Kereiakes; Robert W Yeh; Joseph M Massaro; Priscilla Driscoll-Shempp; Donald E Cutlip; P Gabriel Steg; Anthony H Gershlick; Harald Darius; Ian T Meredith; John Ormiston; Jean Francois Tanguay; Stephan Windecker; Kirk N Garratt; David E Kandzari; David P Lee; Daniel I Simon; Adrian Corneliu Iancu; Jaroslaw Trebacz; Laura Mauri Journal: JAMA Date: 2015-03-17 Impact factor: 56.272
Authors: Peter Clemmensen; Niccolò Grieco; Hüseyin Ince; Nicolas Danchin; Jochen Goedicke; Yvonne Ramos; Josef Schmitt; Patrick Goldstein Journal: Eur Heart J Acute Cardiovasc Care Date: 2014-09-02
Authors: Steen Husted; Stefan James; Richard C Becker; Jay Horrow; Hugo Katus; Robert F Storey; Christopher P Cannon; Magda Heras; Renato D Lopes; Joao Morais; Kenneth W Mahaffey; Richard G Bach; Daniel Wojdyla; Lars Wallentin Journal: Circ Cardiovasc Qual Outcomes Date: 2012-09-01
Authors: Nicolas Danchin; Maddalena Lettino; Uwe Zeymer; Petr Widimsky; Alfredo Bardaji; Jose A Barrabes; Angel Cequier; Marc J Claeys; Leonardo De Luca; Jakob Dörler; David Erlinge; Paul Erne; Patrick Goldstein; Sasha M Koul; Gilles Lemesle; Thomas F Lüscher; Christian M Matter; Gilles Montalescot; Dragana Radovanovic; Jose Lopez Sendón; Petr Tousek; Franz Weidinger; Clive F M Weston; Azfar Zaman; Pontus Andell; Jin Li; J Wouter Jukema Journal: Eur Heart J Cardiovasc Pharmacother Date: 2016-01-27
Authors: Dimitrios Alexopoulos; John A Goudevenos; Ioanna Xanthopoulou; Spyridon Deftereos; George Sitafidis; Ioannis Kanakakis; Michalis Hamilos; Haralambos Parissis; Ioannis V Ntalas; Christos Angelidis; Stylianos Petousis; Manolis Vavuranakis; George Hahalis; Christodoulos Stefanadis Journal: Int J Cardiol Date: 2013-08-15 Impact factor: 4.164
Authors: Marco Roffi; Carlo Patrono; Jean-Philippe Collet; Christian Mueller; Marco Valgimigli; Felicita Andreotti; Jeroen J Bax; Michael A Borger; Carlos Brotons; Derek P Chew; Baris Gencer; Gerd Hasenfuss; Keld Kjeldsen; Patrizio Lancellotti; Ulf Landmesser; Julinda Mehilli; Debabrata Mukherjee; Robert F Storey; Stephan Windecker Journal: Eur Heart J Date: 2015-08-29 Impact factor: 29.983
Authors: Victòria Lorente; Jaime Aboal; Cosme Garcia; Jordi Sans-Roselló; Antonia Sambola; Rut Andrea; Carlos Tomás; Gil Bonet; David Viñas; Nabil El Ouaddi; Santiago Montero; Javier Cantalapiedra; Margarida Pujol; Isabel Hernández; María Pérez-Rodriguez; Isaac Llaó; José C Sánchez-Salado; Miquel Gual; Albert Ariza-Solé Journal: J Geriatr Cardiol Date: 2020-01 Impact factor: 3.327